Bladder cancer follow-up registry for adults in France
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is a real-world registry that collects information during follow-up for certain early-stage bladder cancer. It may help doctors understand how urinary test results relate to recurrence and guide monitoring over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older)
- You are being followed for non-muscle-invasive bladder cancer (an early stage)
- Before your biopsy/resection or when cancer came back, you had a urine test (biomarker)
- You are covered by France social security
- Your follow-up will be done at the study center
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients with early-stage bladder cancer after surgery (TURBT) to see how often the cancer returns and how it affects your daily life.
This trial tests a new study medicine called PF-08052667 for people with a certain type of bladder cancer that hasn't spread into the muscle. It's for those who have already tried BCG treatment and can't or won't have their bladder removed.
This study is collecting blood, urine, and tissue samples from people with high-risk non-muscle invasive bladder cancer to help develop better tests for tracking the disease. By participating, you might help improve future monitoring and treatment decisions.
This is a hospital-based study that builds a clinical and biological database for people treated for rectal cancer at the Montpellier Cancer Institute. It helps researchers organize health information to better understand rectal cancer and improve future care.
This study helps build a population-wide cancer observatory (a real-world cancer record) for people in a specific region of France. It may help researchers better understand cancer patterns and needs in the area.
This study follows people with bladder cancer (except the very earliest Ta stage) to better understand the disease and improve care. You may be asked for basic health information and consent, and joining does not prevent you from joining other studies.
Hear when a new Non Muscle Invasive Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.